Beyond Industry-Academia Partnerships: Extending Ethical Oversight To All Private Neurotechnology Funders [0.03%]
超越产学研合作：向所有私人神经技术资助者扩展伦理监督
Elliana Nath,Gillian E Hue,Roman Palitsky
Elliana Nath
Luke Golemon
Luke Golemon
Nada S Salem
Nada S Salem
Perspectives on Ethical Issues in Neurotechnology Industry-Academia Partnerships: Voices of Industry (Neuro)Ethicists [0.03%]
神经技术行业与学术界合作的伦理问题观点：工业(神经)伦理学家的声音
Anna Schmitt Pereira,Katrina A Bramstedt,Anna Kang et al.
Anna Schmitt Pereira et al.
Neurotechnological Innovation and the Ethics of Collaboration in the Context of Public Healthcare: A Perspective from the UK [0.03%]
神经技术的创新及伦理协作在公共卫生体系中的应用——一个英国视角
Andrew Ivan Brown,Martyn Pickersgill
Andrew Ivan Brown
Is It Time for a (More) Comparative Neuroethics? (And What Might That Look Like?) [0.03%]
comparative neuroethics吗？（又会是什么样的呢？）
Irina Mikhalevich
Irina Mikhalevich
Ian Stevens,Kailyn Price,Kayla R Mehl
Ian Stevens
Deep brain stimulation (DBS) has increasingly been pursued as a treatment for obesity over the past couple of decades. This has occurred despite limited scientific justification or a serious ethical analysis of the concerns it raises. These...
A Review of Dementia Management Act in Korea: Focusing on Data Governance and Ethical Issues [0.03%]
韩国痴呆症管理法述评：聚焦数据治理和伦理问题
Tae-Woo Kang,Ji Hyun Yang,In Young Lee et al.
Tae-Woo Kang et al.
The Republic of Korea is facing a rapidly aging population, with the prevalence of dementia expected to more than double by 2050, which will create major social and economic pressures. The Dementia Management Act (DMA), which came into effe...
Human Disenhancement, Socially Disruptive Technologies, and Legitimate Expectations [0.03%]
人体能力削弱、颠覆性技术与正当期待原则
Jeroen Hopster
Jeroen Hopster
Must Care Be Earned? The Normalization of Sacrifice in Post-Disenhancement Ethics [0.03%]
不必去博取关爱？后削弱时代的伦理与奉献常态化问题
Valerie Black,Maya Hunt
Valerie Black